Author

Erin F. Blau

Observed names: Erin Blau, Erin F Blau

Institution: Centers for Disease Control and Prevention

Observed institutions: Centers for Disease Control and Prevention, United States Public Health Service, National Center on Birth Defects and Developmental Disabilities, Center for Global Health, Epidemic Intelligence Service, Kentucky Department for Public Health, Center for Surveillance, Epidemiology, and Laboratory Services

ORCID: 0000-0002-8967-7856

Observed ORCID: 0000-0002-8967-7856

OpenAlex ID: A5059721715

Characteristics Associated with Hospitalization Among Patients with COVID-19 — Metropolitan Atlanta, Georgia, March–April 2020

2020 · Marie E. Killerby, Ruth Link-Gelles, et al. · MMWR Morbidity and Mortality Weekly Report · 361

Missed Opportunities for Human Immunodeficiency Virus (HIV) Testing During Injection Drug Use–Related Healthcare Encounters Among a Cohort of Persons Who Inject Drugs With HIV Diagnosed During an Outbreak—Cincinnati/Northern Kentucky, 2017–2018

2020 · Nathan W Furukawa, Erin F Blau, et al. · Clinical Infectious Diseases · 28

Progress in Immunization Safety Monitoring — Worldwide, 2020–2022

2023 · Erin F. Blau, Madhava Ram Balakrishnan, et al. · MMWR Morbidity and Mortality Weekly Report · 17

Characteristics and Risk Factors of Hospitalized and Nonhospitalized COVID-19 Patients, Atlanta, Georgia, USA, March–April 2020

2021 · Kristen Pettrone, Eleanor Burnett, et al. · Emerging infectious diseases · 15

Primary Indicators to Systematically Monitor COVID-19 Mitigation and Response — Kentucky, May 19–July 15, 2020

2020 · Kate Varela, Benjamin Scott, et al. · MMWR Morbidity and Mortality Weekly Report · 10

CDC’s COVID-19 International Vaccine Implementation and Evaluation Program and Lessons from Earlier Vaccine Introductions

2022 · Heidi M. Soeters, Reena H. Doshi, et al. · Emerging infectious diseases · 9

High HIV diversity, recombination, and superinfection revealed in a large outbreak among persons who inject drugs in Kentucky and Ohio, USA

2024 · William M Switzer, Anupama Shankar, et al. · Virus Evolution · 8

Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data

2024 · Sonali Kochhar, David N. Assis, et al. · Vaccine · 7

The Occupational Health Effects of Responding to a Natural Gas Pipeline Explosion Among Emergency First Responders – Lincoln County, Kentucky, 2019

2021 · David P. Bui, Esther A. Kukielka, et al. · Disaster Medicine and Public Health Preparedness · 7

Mycobacterium porcinum Skin and Soft Tissue Infections After Vaccinations — Indiana, Kentucky, and Ohio, September 2018–February 2019

2021 · Erin F. Blau, Andrea Flinchum, et al. · MMWR Morbidity and Mortality Weekly Report · 5

Prioritizing interventions to address healthcare worker barriers to reporting adverse events following immunization in Ghana

2025 · Sharon Laryea, Erin Blau, et al. · Vaccine · 2

Population-Based Linked Longitudinal Surveillance of Pregnant People and Their Infants: A Critical Resource for Emerging, Re-Emerging, and Persistent Threats

2022 · Van T. Tong, Kate R. Woodworth, et al. · Journal of Women s Health · 2

Strengthening New Vaccine Introduction in Low- and Middle-Income Countries: Establishing Hospital-Based Sentinel Surveillance for Vaccine Safety Monitoring

2025 · Anna Shaum, Erin Blau, et al. · American Journal of Tropical Medicine and Hygiene · 1

Enhancing reporting of adverse events following immunization (AEFI) in Malawi: A one-year follow-up evaluation of frontline healthcare workers' knowledge retention after AEFI surveillance training

2026 · Lapani Ngala, Erin Blau, et al. · Vaccine X

Works count: 14

Citation count: 472

H-index: 7

I10-index: 5